AVITA Medical, Inc. (ASX:AVH)

Aerovate Therapeutics Statistics

Total Valuation

AVITA Medical has a market cap or net worth of AUD 224.39 million. The enterprise value is 268.61 million.

Market Cap	224.39M
Enterprise Value	268.61M

Important Dates

The last earnings date was Thursday, August 7, 2025.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+2.60%
Shares Change (QoQ)	+0.43%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	25.95M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.96
PB Ratio	-11.41
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.41
EV / Sales	2.34
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.20

Financial Position

The company has a current ratio of 0.58

Current Ratio	0.58
Quick Ratio	0.43
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-1.06
Interest Coverage	-0.22

Financial Efficiency

Return on equity (ROE) is -935.73% and return on invested capital (ROIC) is -58.02%.

Return on Equity (ROE)	-935.73%
Return on Assets (ROA)	-40.03%
Return on Invested Capital (ROIC)	-58.02%
Return on Capital Employed (ROCE)	1,046.08%
Revenue Per Employee	439,310
Profits Per Employee	-302,555
Employee Count	260
Asset Turnover	1.03
Inventory Turnover	1.65

Taxes

In the past 12 months, AVITA Medical has paid 4,576 in taxes.

Income Tax	4,576
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.10% in the last 52 weeks. The beta is 1.63, so AVITA Medical's price volatility has been higher than the market average.

Beta (5Y)	1.63
52-Week Price Change	-43.10%
50-Day Moving Average	1.70
200-Day Moving Average	2.74
Relative Strength Index (RSI)	50.09
Average Volume (20 Days)	620,371

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	17.48

Income Statement

In the last 12 months, AVITA Medical had revenue of AUD 114.22 million and -78.66 million in losses. Loss per share was -3.00.

Revenue	114.22M
Gross Profit	96.26M
Operating Income	-71.29M
Pretax Income	-78.66M
Net Income	-78.66M
EBITDA	-68.56M
EBIT	-71.29M
Loss Per Share	-3.00

Balance Sheet

The company has 23.93 million in cash and 68.01 million in debt, giving a net cash position of -44.08 million.

Cash & Cash Equivalents	23.93M
Total Debt	68.01M
Net Cash	-44.08M
Net Cash Per Share	n/a
Equity (Book Value)	-19.66M
Book Value Per Share	-0.74
Working Capital	-40.19M

Cash Flow

In the last 12 months, operating cash flow was -54.66 million and capital expenditures -9.33 million, giving a free cash flow of -63.99 million.

Operating Cash Flow	-54.66M
Capital Expenditures	-9.33M
Free Cash Flow	-63.99M
FCF Per Share	n/a

Margins

Gross margin is 84.28%, with operating and profit margins of -62.42% and -68.87%.

Gross Margin	84.28%
Operating Margin	-62.42%
Pretax Margin	-68.87%
Profit Margin	-68.87%
EBITDA Margin	-60.02%
EBIT Margin	-62.42%
FCF Margin	n/a

Dividends & Yields

AVITA Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.60%
Shareholder Yield	n/a
Earnings Yield	-35.06%
FCF Yield	-28.52%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 24, 2020. It was a reverse split with a ratio of 0.05.

Last Split Date	Jun 24, 2020
Split Type	Reverse
Split Ratio	0.05

Scores

AVITA Medical has an Altman Z-Score of -9.05 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.05
Piotroski F-Score	2